Health Sciences Acquisitions Corporation

Immunovant set to land on Nasdaq via HSAC merger
Fierce Biotech
Wed, 10/2/19 - 10:56 am
Immunovant
NASDAQ
M&A
Health Sciences Acquisitions Corporation